| Period Ending | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 | Mar 30, 2012 |
|---|
|
Total Revenue
|
32,570
|
12,968
|
14,506
|
33,772
| | Cost of Revenue | 18,832 | 6,174 | 6,716 | 20,064 | | |
Gross Profit
|
13,738
|
6,795
|
7,789
|
13,709
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 7,921 | 6,140 | 6,434 | 6,447 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others | 1,494 | 1,368 | 1,344 | 1,281 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
4,323
|
(713)
|
12
|
5,980
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (195) | (77) | (449) | (72) |
|
Earnings Before Interest And Taxes | 4,127 | (794) | (439) | 5,906 |
|
Interest Expense | 796 | 637 | 626 | 664 |
|
Income Before Tax | 3,331 | (1,431) | (1,065) | 5,242 |
|
Income Tax Expense | 1,499 | (760) | (341) | 1,959 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 1,832 | (675) | (726) | 3,280 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
1,832
|
(671)
|
(724)
|
3,283
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
1,832
|
(671)
|
(724)
|
3,283
|
|
0.21(2.01%) 1:23PM EDT - Nasdaq Real Time Price